Background: Nasopharyngeal carcinoma (NPC) is an important tumor in many co
untries. Ethnic and regional factors strongly influence disease risk. NPC i
s usually diagnosed late in disease development, and 10-year survival rates
are as low as 10%. Epstein-Barr virus (EBV), a possibly causative agent, i
s present in all cells of essentially all undifferentiated NPCs. We wished
to determine the following: 1) whether an ambulatory nasopharyngeal brush b
iopsy could provide sufficient tumor cell DNA for the detection of EBV and
2) whether the detection of EBV in this locale reflects the presence of tum
or cells or simply EBV carrier status. Methods: We collected nasopharyngeal
tissue via ambulatory brush biopsies from 21 patients with newly diagnosed
NPC and from 157 subjects with other otolaryngologic complaints. The major
ity of study subjects were from highrisk populations. Sample DNA was analyz
ed for the presence of EBV genomic sequences by use of the polymerase chain
reaction (PCR). Results: Ninety-six percent of samples yielded sufficient
DNA for PCR amplification. Nineteen of 21 patients with NPC brushed positiv
e for EBV DNA, while all but two (1.3%) of 149 informative control subjects
were negative for EBV (two-sided P<.0001). One of the EBV-positive control
subjects had an EBV-positive inverted sinonasal papilloma; the other EBV-p
ositive control subject exhibited no overt clinical disease. Conclusion: De
monstration of EBV DNA in nasopharyngeal brush biopsy specimens detects NPC
with a sensitivity of at least 90% (95% confidence interval = 89.63%-91.32
%) and a specificity of approximately 99% (95% confidence interval = 98.64%
-98.68%). This technique merits further testing as a possible ambulatory sc
reening strategy in high-risk populations.